Candid Health Raises $120M for AI-Driven Healthcare Finance

Candid Health has successfully closed a substantial $120 million Series D funding round, signaling a significant advancement in its mission to automate the intricate financial operations within the U.S. healthcare system. The investment, spearheaded by Sixth Street Growth, the growth equity arm of global investment firm Sixth Street, underscores the market's confidence in Candid Health's innovative approach to revenue cycle management (RCM). The round also saw continued support from existing investors, including Oak HC/FT and 8VC, alongside participation from Y Combinator.

This latest capital infusion represents a remarkable threefold increase in the company's valuation compared to its Series C financing in early 2025. Candid Health is tackling the inefficiencies plaguing the estimated $280 billion spent annually on healthcare RCM. By rebuilding the foundational financial infrastructure from the ground up, the company leverages advanced automation and artificial intelligence to streamline the complex processes that govern provider reimbursement.

The healthcare industry faces mounting pressure from escalating operational costs and increasingly complex billing environments. Legacy systems are proving inadequate to manage the scale and intricacies of modern healthcare delivery. Candid Health's platform addresses this by unifying disparate clinical, billing, and provider data into a cohesive model. This comprehensive data context empowers its AI engine to execute tasks previously handled manually by billing departments, driving unprecedented efficiency gains.

Nick Perry, Co-founder and CEO of Candid Health, emphasized the company's foundational approach. "We've spent seven years meticulously reconstructing the core infrastructure for healthcare finance," Perry stated. "Unlike competitors who merely layer AI onto outdated systems, we've built a truly modern solution that delivers demonstrable cost reductions and collection improvements that are transforming the industry." The company reports a 190% year-over-year growth in annual contracted revenue and a 180% net dollar retention rate for 2025, reflecting strong market adoption.

Alex Katz, Managing Director at Sixth Street Growth, highlighted the company's customer-centricity and technological prowess. "Candid Health's deep understanding of provider challenges and their development of an agentic AI-powered revenue cycle transformation are truly differentiated," Katz commented. "Our extensive conversations with nearly 40 of their clients revealed overwhelmingly positive feedback, consistently praising the platform's profound impact on underlying practice operations." This validation from a significant portion of their customer base speaks volumes about the platform's efficacy.

Candid Health's platform is designed to function as the financial system of record for hundreds of leading U.S. healthcare providers across diverse specialties. By automating routine tasks and providing actionable insights for remaining manual processes, the platform aims to free up healthcare organizations to concentrate on their primary mission: delivering quality patient care. The company's strategic expansion, fueled by this new funding, is expected to further solidify its position as a leader in the healthtech RCM space.